128 related articles for article (PubMed ID: 38887181)
21. Relationship between regional left ventricular dysfunction and cancer-therapy-related cardiac dysfunction.
Saijo Y; Kusunose K; Okushi Y; Yamada H; Toba H; Sata M
Heart; 2020 Nov; 106(22):1752-1758. PubMed ID: 32209616
[TBL] [Abstract][Full Text] [Related]
22. Early detection of subclinical left ventricular dysfunction after breast cancer radiation therapy using speckle-tracking echocardiography: association between cardiac exposure and longitudinal strain reduction (BACCARAT study).
Walker V; Lairez O; Fondard O; Pathak A; Pinel B; Chevelle C; Franck D; Jimenez G; Camilleri J; Panh L; Broggio D; Derreumaux S; Bernier MO; Laurier D; Ferrières J; Jacob S
Radiat Oncol; 2019 Nov; 14(1):204. PubMed ID: 31727075
[TBL] [Abstract][Full Text] [Related]
23. Right ventricle involvement in patients with breast cancer treated with chemotherapy.
Rossetto L; Di Lisi D; Madaudo C; Sinagra FP; Di Palermo A; Triolo OF; Gambino G; Ortello A; Galassi AR; Novo G
Cardiooncology; 2024 Apr; 10(1):24. PubMed ID: 38616279
[TBL] [Abstract][Full Text] [Related]
24. Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunction.
Santoro C; Esposito R; Lembo M; Sorrentino R; De Santo I; Luciano F; Casciano O; Giuliano M; De Placido S; Trimarco B; Lancellotti P; Arpino G; Galderisi M
Eur Heart J Cardiovasc Imaging; 2019 Dec; 20(12):1345-1352. PubMed ID: 31326981
[TBL] [Abstract][Full Text] [Related]
25. Early evaluation of subclinical cardiotoxicity in patients with lung cancer receiving immune checkpoint inhibitors by cardiovascular magnetic resonance: a prospective observational study.
Liu J; Cao Y; Zhu K; Yao S; Yuan M; Kong X; Liu X; Li Y; Cui Y; Han X; Zhou X; Meng R; Shi H
Quant Imaging Med Surg; 2022 Oct; 12(10):4771-4785. PubMed ID: 36185042
[TBL] [Abstract][Full Text] [Related]
26. Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin.
Lee SH; Cho I; You SC; Cha MJ; Chang JS; Kim WD; Go KY; Kim DY; Seo J; Shim CY; Hong GR; Kang SM; Ha JW; Rha SY; Kim HS
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565449
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices.
Di Lisi D; Manno G; Madaudo C; Filorizzo C; Intravaia RCM; Galassi AR; Incorvaia L; Russo A; Novo G
Int J Cardiovasc Imaging; 2023 Oct; 39(10):1845-1853. PubMed ID: 37548845
[TBL] [Abstract][Full Text] [Related]
28. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility.
Santoro C; Arpino G; Esposito R; Lembo M; Paciolla I; Cardalesi C; de Simone G; Trimarco B; De Placido S; Galderisi M
Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):930-936. PubMed ID: 28379383
[TBL] [Abstract][Full Text] [Related]
29. The Predictive Value of 2D Myocardial Strain for Epirubicin-Induced Cardiotoxicity.
Ben Abdallah I; Ben Nasr S; Chourabi C; Boukhris M; Ben Abdallah I; Zribi A; Fendri S; Balti M; Fehri W; Chraiet N; Haddaoui A
J Oncol; 2020; 2020():5706561. PubMed ID: 33335549
[TBL] [Abstract][Full Text] [Related]
30. Left atrial reservoir longitudinal strain and its incremental value to the left ventricular global longitudinal strain in predicting anthracycline-induced cardiotoxicity.
Li Z; Zhao R; Zhang Q; Shen Y; Shu X; Cheng L
Echocardiography; 2024 Apr; 41(4):e15805. PubMed ID: 38558436
[TBL] [Abstract][Full Text] [Related]
31. Myocardial injury detected by T1 and T2 mapping on CMR predicts subsequent cancer therapy-related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided RT.
Tahir E; Azar M; Shihada S; Seiffert K; Goy Y; Beitzen-Heineke A; Molwitz I; Muellerleile K; Stehning C; Schön G; Adam G; Petersen C; Müller V; Lund GK
Eur Radiol; 2022 Mar; 32(3):1853-1865. PubMed ID: 34536111
[TBL] [Abstract][Full Text] [Related]
32. Alterations in Left Atrial Strain in Breast Cancer Patients Immediately Post Anthracycline Exposure.
Emerson P; Stefani L; Boyd A; Richards D; Hui R; Altman M; Thomas L
Heart Lung Circ; 2024 May; 33(5):684-692. PubMed ID: 37806911
[TBL] [Abstract][Full Text] [Related]
33. Association of Left Ventricular Global Longitudinal Strain With Asymptomatic Severe Aortic Stenosis: Natural Course and Prognostic Value.
Vollema EM; Sugimoto T; Shen M; Tastet L; Ng ACT; Abou R; Marsan NA; Mertens B; Dulgheru R; Lancellotti P; Clavel MA; Pibarot P; Genereux P; Leon MB; Delgado V; Bax JJ
JAMA Cardiol; 2018 Sep; 3(9):839-847. PubMed ID: 30140889
[TBL] [Abstract][Full Text] [Related]
34. Two-dimensional speckle tracking echocardiography help identify breast cancer therapeutics-related cardiac dysfunction.
Liu W; Li W; Li H; Li Z; Zhao P; Guo Z; Liu C; Sun L; Wang Z
BMC Cardiovasc Disord; 2022 Dec; 22(1):548. PubMed ID: 36522712
[TBL] [Abstract][Full Text] [Related]
35. Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer.
Tang Q; Jiang Y; Xu Y; Xia H
J Clin Ultrasound; 2017 May; 45(4):222-230. PubMed ID: 27910996
[TBL] [Abstract][Full Text] [Related]
36. Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab.
Bergamini C; Niro L; Springhetti P; Ferri L; Trento L; Minnucci I; Maffeis C; Tafciu E; Rossi A; Fiorio E; Benfari G; Ribichini F
Cardiovasc Toxicol; 2024 Jun; 24(6):550-562. PubMed ID: 38696070
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of Global Longitudinal Strain for Early Identification of Subclinical Left Ventricular Dysfunction in Patients With Active Cancer.
Laufer-Perl M; Derakhshesh M; Milwidsky A; Mor L; Ravid D; Amrami N; Sherez J; Keren G; Topilsky Y; Arbel Y
Am J Cardiol; 2018 Nov; 122(10):1784-1789. PubMed ID: 30217373
[TBL] [Abstract][Full Text] [Related]
38. Baseline Global Longitudinal Strain as a Predictor of Left Ventricular Dysfunction and Hospitalization for Heart Failure of Patients With Malignant Lymphoma After Anthracycline Therapy.
Hatazawa K; Tanaka H; Nonaka A; Takada H; Soga F; Hatani Y; Matsuzoe H; Shimoura H; Ooka J; Sano H; Mochizuki Y; Matsumoto K; Hirata KI
Circ J; 2018 Sep; 82(10):2566-2574. PubMed ID: 29984789
[TBL] [Abstract][Full Text] [Related]
39. Global longitudinal strain: an early marker for cardiotoxicity in patients treated for breast cancer.
van der Linde D; van Hagen I; Veen K; Zuetenhorst H; van Dalen B
Neth Heart J; 2023 Mar; 31(3):103-108. PubMed ID: 36434383
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Myocardial Work in Cancer Therapy-Related Cardiac Dysfunction and Analysis of CTRCD Prediction by Echocardiography.
Guan J; Bao W; Xu Y; Yang W; Li M; Xu M; Zhang Y; Zhang M
Front Pharmacol; 2021; 12():770580. PubMed ID: 34858189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
